Maximus director Michael J. Warren buys $3,032 in stock

In a recent series of transactions, Michael J. Warren, director at Maximus, Inc. (NYSE:MMS), has invested a total of $3,032 in the company's stock through the purchase of shares at varying prices. The transactions, which took place over several months, indicate a price range between $84.05 and $92.4 for the shares acquired.

The series of purchases began on February 29, 2024, when Warren acquired shares at a price of $84.05 each. The buying continued over the subsequent months, with additional purchases made at prices of $84.97 and $92.4. These transactions were made as part of a dividend reinvestment plan, which allows shareholders to use their dividend payouts to purchase additional shares of the company's stock.

Following these transactions, Warren's ownership in Maximus has increased, reflecting a positive stance on the company's future performance. The purchases are part of normal investment activity for directors and executives who may choose to increase their stake in the company they manage.

Investors often monitor insider transactions like these for insights into the confidence that company executives and directors have in the firm's prospects. Insider buying, in particular, can be seen as a bullish signal, as it may suggest that those with the most knowledge of the company anticipate positive developments.

Maximus, Inc., headquartered in McLean, Virginia, is known for providing business services and solutions to government health and human services agencies around the world. The company's commitment to delivering effective and innovative solutions has positioned it as a leader in its field.

The details of these stock purchases were disclosed in a Form 4 filing with the Securities and Exchange Commission, as required by federal securities laws. These filings provide transparency into the trading activities of company insiders, offering investors a glimpse into their investment decisions.

In other recent news, Maximus has been making significant strides in securing lucrative contracts and reporting substantial financial growth. The company recently secured a five-year contract valued at $263 million with the Pennsylvania Department of Human Services and a $20 million contract with the Office of Personnel Management. These contracts extend Maximus's commitment to improving service delivery and customer satisfaction.

In recent financial developments, Maximus reported a 10.6% year-over-year revenue increase to $1.31 billion in Q3 of the fiscal year 2024. This growth was primarily driven by a 17.0% revenue increase in the U.S. Federal Services segment. The company also reported an adjusted operating income margin of 12.6% and an adjusted EPS of $1.74. Full-year guidance for FY2024 was raised, with revenue expected to reach between $5.25 billion and $5.35 billion, adjusted operating income between $570 million and $590 million, and adjusted EPS between $6 and $6.20 per share.

Looking forward to FY2025, Maximus anticipates similar revenue levels and targets at least a 10% adjusted operating income margin. Maximus has also recently won contracts totaling over $596 million with various entities such as the IRS, TSA, and FEMA. Despite a protest filed against the CMS contract, Maximus remains confident in its growth prospects and its ability to navigate policy changes and administration shifts.

InvestingPro Insights

The recent insider purchases by Michael J. Warren, a director at Maximus, Inc. (NYSE:MMS), align with several positive indicators for the company as reflected in the InvestingPro data and tips. Maximus, Inc. has been trading at a P/E ratio of 17.98, which is relatively low compared to its near-term earnings growth, suggesting that the stock may be undervalued. This is supported by the InvestingPro Tip highlighting that the stock is trading at a low P/E ratio relative to near-term earnings growth. Moreover, the company has a strong financial foundation, with liquid assets surpassing short-term obligations, as noted in another InvestingPro Tip.

From the financial metrics provided by InvestingPro, Maximus, Inc. has a market capitalization of $5.19 billion and has shown a revenue growth of 8.89% over the last twelve months as of Q3 2024. This growth is further evidenced by a 10.62% quarterly revenue increase in Q3 2024. Additionally, the company's gross profit margin stands at 23.63%, with an operating income margin of 9.08%, indicating efficient management and a solid profitability framework.

These financial health indicators and the confidence shown by insider transactions could be a signal for potential investors. For those interested in a deeper analysis, there are additional InvestingPro Tips available on the Maximus, Inc. page at https://www.investing.com/pro/MMS, which provide further insights into the company's performance and prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.